Diane MacDougall

2.7k total citations
42 papers, 2.1k citations indexed

About

Diane MacDougall is a scholar working on Surgery, Cancer Research and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Diane MacDougall has authored 42 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Surgery, 11 papers in Cancer Research and 9 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Diane MacDougall's work include Lipoproteins and Cardiovascular Health (26 papers), Cancer, Lipids, and Metabolism (10 papers) and Cholesterol and Lipid Metabolism (6 papers). Diane MacDougall is often cited by papers focused on Lipoproteins and Cardiovascular Health (26 papers), Cancer, Lipids, and Metabolism (10 papers) and Cholesterol and Lipid Metabolism (6 papers). Diane MacDougall collaborates with scholars based in United States, Canada and United Kingdom. Diane MacDougall's co-authors include Peter J.H. Jones, Fady Ntanios, Catherine A. Vanstone, Janice R. Margulies, Christie M. Ballantyne, Jeffrey C. Hanselman, Roger S. Newton, Harold Bays, James M. McKenney and John Rubino and has published in prestigious journals such as Circulation, SHILAP Revista de lepidopterología and Journal of the American College of Cardiology.

In The Last Decade

Diane MacDougall

40 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Diane MacDougall United States 17 1.4k 510 438 361 344 42 2.1k
Maud N. Vissers Netherlands 30 1.6k 1.1× 597 1.2× 282 0.6× 293 0.8× 339 1.0× 48 2.6k
Khadija Ouguerram France 26 966 0.7× 641 1.3× 555 1.3× 220 0.6× 326 0.9× 101 2.1k
Mary R. Dicklin United States 27 878 0.6× 632 1.2× 354 0.8× 906 2.5× 176 0.5× 78 2.3k
B Jacotot France 27 1.0k 0.7× 562 1.1× 485 1.1× 498 1.4× 331 1.0× 124 2.2k
Dragana Nikolić Italy 32 885 0.6× 1.0k 2.0× 710 1.6× 139 0.4× 236 0.7× 78 2.6k
Franco Pazzucconi Italy 26 719 0.5× 553 1.1× 298 0.7× 459 1.3× 141 0.4× 48 1.7k
Tatu Miettinen Finland 15 924 0.7× 429 0.8× 270 0.6× 195 0.5× 236 0.7× 24 1.4k
Dawn E. Telford Canada 27 876 0.6× 548 1.1× 792 1.8× 211 0.6× 242 0.7× 45 2.1k
Irene F. Gazi Greece 21 711 0.5× 668 1.3× 301 0.7× 111 0.3× 289 0.8× 35 1.6k
D.W. Erkelens Netherlands 32 1.2k 0.9× 1.5k 2.9× 497 1.1× 286 0.8× 403 1.2× 85 2.9k

Countries citing papers authored by Diane MacDougall

Since Specialization
Citations

This map shows the geographic impact of Diane MacDougall's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Diane MacDougall with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Diane MacDougall more than expected).

Fields of papers citing papers by Diane MacDougall

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Diane MacDougall. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Diane MacDougall. The network helps show where Diane MacDougall may publish in the future.

Co-authorship network of co-authors of Diane MacDougall

This figure shows the co-authorship network connecting the top 25 collaborators of Diane MacDougall. A scholar is included among the top collaborators of Diane MacDougall based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Diane MacDougall. Diane MacDougall is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
MacDougall, Diane, Anne Tybjærg-Hansen, Joshua W. Knowles, et al.. (2025). Lipoprotein(a) and recurrent atherosclerotic cardiovascular events: the US Family Heart Database. European Heart Journal. 46(44). 4762–4775. 8 indexed citations
2.
Basit, Mujeeb, Ruth Schneider, Colby Ayers, et al.. (2025). Performance of the FIND-FH machine learning algorithm for the identification of individuals with suspected familial hypercholesterolemia. Journal of clinical lipidology. 19(4). 1037–1043. 1 indexed citations
3.
4.
Amore, Benny, Clay T. Cramer, Diane MacDougall, & Maurice G. Emery. (2023). The Disposition and Metabolism of Bempedoic Acid, a Potent Inhibitor of ATP Citrate Lyase, in Healthy Human Subjects. Drug Metabolism and Disposition. 51(5). 599–609. 13 indexed citations
5.
Amore, Benny, Diane MacDougall, Jeffrey C. Hanselman, & Maurice G. Emery. (2023). Phase 1, Single‐ and Multiple‐Ascending‐Dose, Food‐Effect, and East Asian Subject Studies to Assess the Pharmacokinetics, Safety, and Tolerability of Bempedoic Acid, a Selective Inhibitor of Adenosine Triphosphate Citrate Lyase. Clinical Pharmacology in Drug Development. 12(10). 1022–1035. 2 indexed citations
6.
Laufs, Ulrich, Christie M. Ballantyne, Maciej Banach, et al.. (2022). Efficacy and safety of bempedoic acid in patients not receiving statins in phase 3 clinical trials. Journal of clinical lipidology. 16(3). 286–297. 26 indexed citations
7.
Catapano, Alberico L., Harold Bays, Maciej Banach, et al.. (2020). BEMPEDOIC ACID EFFICACY AND SAFETY IN HIGH CVD RISK PATIENTS TREATED WITH OR WITHOUT EZETIMIBE: POOLED ANALYSIS OF 4 PHASE 3 CLINICAL TRIALS. Journal of the American College of Cardiology. 75(11). 1987–1987. 1 indexed citations
8.
Rubino, John, Diane MacDougall, Lulu Ren Sterling, Jeffrey C. Hanselman, & Stephen J. Nicholls. (2020). Combination of bempedoic acid, ezetimibe, and atorvastatin in patients with hypercholesterolemia: A randomized clinical trial. Atherosclerosis. 320. 122–128. 60 indexed citations
9.
Lalwani, Narendra D., Jeffrey C. Hanselman, Diane MacDougall, Lulu Ren Sterling, & Clay T. Cramer. (2019). Complementary low-density lipoprotein-cholesterol lowering and pharmacokinetics of adding bempedoic acid (ETC-1002) to high-dose atorvastatin background therapy in hypercholesterolemic patients: A randomized placebo-controlled trial. Journal of clinical lipidology. 13(4). 568–579. 55 indexed citations
10.
Ballantyne, Christie M., James M. McKenney, Diane MacDougall, et al.. (2016). Effect of ETC-1002 on Serum Low-Density Lipoprotein Cholesterol in Hypercholesterolemic Patients Receiving Statin Therapy. The American Journal of Cardiology. 117(12). 1928–1933. 94 indexed citations
11.
Thompson, Paul D., Diane MacDougall, Roger S. Newton, et al.. (2016). Treatment with ETC-1002 alone and in combination with ezetimibe lowers LDL cholesterol in hypercholesterolemic patients with or without statin intolerance. Journal of clinical lipidology. 10(3). 556–567. 118 indexed citations
12.
Thompson, Paul D., Christie M. Ballantyne, James McKenney, et al.. (2015). ETC-1002 LOWERS LDL-C MORE THAN EZETIMIBE IN PATIENTS WITH HYPERCHOLESTEROLEMIA WITH OR WITHOUT STATIN INTOLERANCE AND HAS A SIMILAR SAFETY AND TOLERABILITY PROFILE. Journal of the American College of Cardiology. 65(10). A1349–A1349. 5 indexed citations
13.
Thompson, Paul M., John Rubino, Matthew Janik, et al.. (2015). Use of ETC-1002 to treat hypercholesterolemia in patients with statin intolerance. Journal of clinical lipidology. 9(3). 295–304. 121 indexed citations
14.
Gutiérrez, María J., Diane MacDougall, Jeffrey C. Hanselman, et al.. (2014). Efficacy and Safety of ETC-1002, a Novel Investigational Low-Density Lipoprotein-Cholesterol–Lowering Therapy for the Treatment of Patients With Hypercholesterolemia and Type 2 Diabetes Mellitus. Arteriosclerosis Thrombosis and Vascular Biology. 34(3). 676–683. 135 indexed citations
15.
16.
Ballantyne, Christie M., Michael H. Davidson, Diane MacDougall, et al.. (2013). Efficacy and Safety of a Novel Dual Modulator of Adenosine Triphosphate-Citrate Lyase and Adenosine Monophosphate-Activated Protein Kinase in Patients With Hypercholesterolemia. Journal of the American College of Cardiology. 62(13). 1154–1162. 136 indexed citations
17.
Ballantyne, Christie M., Michael Davidson, Diane MacDougall, Janice R. Margulies, & Lorenzo A. DiCarlo. (2012). ETC-1002 LOWERS LDL-C AND BENEFICIALLY MODULATES OTHER CARDIO-METABOLIC RISK FACTORS IN HYPERCHOLESTEROLEMIC SUBJECTS WITH EITHER NORMAL OR ELEVATED TRIGLYCERIDES. Journal of the American College of Cardiology. 59(13). E1625–E1625. 8 indexed citations
18.
Bays, Harold, James M. McKenney, Carlos A. Dujovne, et al.. (2003). Effectiveness and tolerability of a new lipid-altering agent, gemcabene, in patients with low levels of high-density lipoprotein cholesterol. The American Journal of Cardiology. 92(5). 538–543. 40 indexed citations
19.
Jones, Peter J.H., Diane MacDougall, Fady Ntanios, & Catherine A. Vanstone. (1997). Dietary phytosterols as cholesterol-lowering agents in humans. Canadian Journal of Physiology and Pharmacology. 75(3). 217–227. 240 indexed citations
20.
MacDougall, Diane, Peter J.H. Jones, Janet A Vogt, P. Terry Phang, & David D. Kitts. (1996). Utilization of myristic and palmitic acid in humans fed different dietary fats. European Journal of Clinical Investigation. 26(9). 755–762. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Maud N. Vissers Breakdown of academic impact, for papers by Khadija Ouguerram Breakdown of academic impact, for papers by Mary R. Dicklin Breakdown of academic impact, for papers by B Jacotot Breakdown of academic impact, for papers by Dragana Nikolić Breakdown of academic impact, for papers by Franco Pazzucconi Breakdown of academic impact, for papers by Tatu Miettinen Breakdown of academic impact, for papers by Dawn E. Telford Breakdown of academic impact, for papers by Irene F. Gazi Breakdown of academic impact, for papers by D.W. Erkelens
Rankless by CCL
2026